Kiromic BioPharma Inc.

Kiromic BioPharma Inc is a bio-technology company. The company is a gene editing which utilizes artificial intelligence and proprietary neural network platform with a therapeutic focus on immuno-oncology.

Investing News NetworkYour trusted source for investing success

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

Leigh Goehring: Gold's "Massive Bull Market" Just Starting; Uranium and Copper Outlook

10 Top Oil-producing Countries (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Top 4 Largest Lithium Reserves by Country (Updated 2024)

First Helium Reviewing Potential Follow Up Targets to Leduc Anomaly Drill

McDermitt PFS Demonstrates Multi-Decade Competitive Source of US Lithium Carbonate

Radiopharm achieves Nasdaq listing of ADS

First Helium Initiates Process to License & Drill the Leduc Anomaly

HyProMag USA Feasibility Study Demonstrates Robust Economics and the Opportunity to Develop a Major New, Domestic Source of Recycled Rare Earths Magnets for the United States

Rua Gold Completes the Acquisition of Siren Gold's Reefton Assets and Becomes the Dominant Reefton Goldfield Explorer

Purpose Bitcoin ETF

First Helium

Soma Gold Corp.

Rua Gold

2024 Gold Outlook Report

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Graphite Outlook Report

Kiromic BioPharma Inc.

5 US Longevity and Anti-aging Stocks to Watch in 2024

Stem Cell Stocks: 10 Biggest NASDAQ Companies

Interactive Chart